We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+8.95%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$2.06B
AUM Growth
+$107M
Cap. Flow
-$28.6M
Cap. Flow %
-1.39%
Top 10 Hldgs %
29.47%
Holding
2,720
New
413
Increased
568
Reduced
616
Closed
259

Sector Composition

Rank Sector Weight
1 Technology 24.3%
2 Healthcare 11.82%
3 Financials 10.45%
4 Consumer Discretionary 9.39%
5 Industrials 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPCE icon
1376
Virgin Galactic
SPCE
$512M
$53.6K ﹤0.01%
690
+37
+6% +$2.93K
LFST icon
1377
Lifestance Health
LFST
$4.71B
$53.6K ﹤0.01%
5,866
+1,709
+41% +$14.2K
RYZ
1378
Ryerson Holding Corp
RYZ
$1.52B
$53.5K ﹤0.01%
1,233
+142
+13% +$5.27K
DOLE icon
1379
Dole
DOLE
$1.26B
$53.5K ﹤0.01%
+3,955
New +$50.7K
MCRI icon
1380
Monarch Casino & Resort
MCRI
$2.24B
$53.5K ﹤0.01%
759
PRM icon
1381
Perimeter Solutions
PRM
$5.54B
$53.3K ﹤0.01%
+8,667
New +$58.1K
ASIX icon
1382
AdvanSix
ASIX
$455M
$53.1K ﹤0.01%
1,518
LGF.B
1383
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$53.1K ﹤0.01%
6,356
+348
+6% +$3.42K
MTUS icon
1384
Metallus
MTUS
$907M
$53K ﹤0.01%
2,458
NABL icon
1385
N-able
NABL
$684M
$53K ﹤0.01%
3,677
PTLO icon
1386
Portillo's
PTLO
$365M
$53K ﹤0.01%
2,351
+662
+39% +$13.8K
EAF icon
1387
GrafTech
EAF
$201M
$52.8K ﹤0.01%
1,048
FLNA
1388
Filana Therapeutics
FLNA
$44.8M
$52.8K ﹤0.01%
2,153
HOPE icon
1389
Hope Bancorp
HOPE
$1.86B
$52.8K ﹤0.01%
6,268
VBTX
1390
DELISTED
Veritex Holdings
VBTX
$52.7K ﹤0.01%
2,941
UUUU icon
1391
Energy Fuels
UUUU
$3.8B
$52.7K ﹤0.01%
8,438
VERV
1392
DELISTED
Verve Therapeutics
VERV
$52.5K ﹤0.01%
2,798
CCF
1393
DELISTED
Chase Corporation
CCF
$52K ﹤0.01%
429
REPL icon
1394
Replimune Group
REPL
$1.42B
$51.8K ﹤0.01%
2,229
-299
-12% -$5.84K
UHT
1395
Universal Health Realty Income Trust
UHT
$575M
$51.6K ﹤0.01%
1,084
-3
-0.3% -$138
NG icon
1396
NovaGold Resources
NG
$3.51B
$51.5K ﹤0.01%
12,917
ESMT
1397
DELISTED
EngageSmart, Inc.
ESMT
$51.4K ﹤0.01%
2,691
+815
+43% +$14.5K
CRNX icon
1398
Crinetics Pharmaceuticals
CRNX
$8.98B
$51.3K ﹤0.01%
2,849
ARLO icon
1399
Arlo Technologies
ARLO
$1.55B
$51.3K ﹤0.01%
4,705
SIBN icon
1400
SI-BONE Inc
SIBN
$848M
$51.3K ﹤0.01%
1,902
+130
+7% +$3.17K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2023 Portfolio in Review

As of Q2 2023, Metropolitan Life Insurance Company (MetLife) held 2,720 positions worth $2.06B, up 5.5% from $1.95B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q2 2023 filing shows 413 new, 568 increased, 616 reduced and 259 closed positions. Its largest new stake was Alphabet (Google) Class C: 222,708 shares worth $26.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $16.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2023 buy was Alphabet (Google) Class C: 222,708 shares worth $26.9M.
  • Metropolitan Life Insurance Company (MetLife) added most to Vanguard Total Bond Market in Q2 2023, an estimated $15M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $16.1M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Iridium Communications in Q2 2023, selling an estimated $418K.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 29% of its $2.06B portfolio in Q2 2023.
  • Metropolitan Life Insurance Company (MetLife) opened 413 new positions and closed 259 in Q2 2023.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 5.5% quarter-over-quarter to $2.06B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.